Mirae Asset Global ETFs Holdings
CORT icon

Mirae Asset Global ETFs Holdings’s Corcept Therapeutics CORT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Sell
11,830
-4,214
-26% -$254K ﹤0.01% 1617
2026
Q1 		$647K Buy
16,044
+6,512
+68% +$243K ﹤0.01% 1745
2025
Q4 		$332K Buy
9,532
+460
+5% +$36.1K ﹤0.01% 2107
2025
Q3 		$754K Buy
9,072
+1,180
+15% +$85.4K ﹤0.01% 1660
2025
Q2 		$579K Sell
7,892
-48,461
-86% -$3.51M ﹤0.01% 1745
2025
Q1 		$6.44M Buy
56,353
+10,320
+22% +$628K 0.01% 688
2024
Q4 		$2.32M Buy
46,033
+1,790
+4% +$93.8K ﹤0.01% 1053
2024
Q3 		$2.05M Buy
44,243
+3,568
+9% +$127K ﹤0.01% 1112
2024
Q2 		$1.32M Buy
+40,675
New +$1.11M ﹤0.01% 1304

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CORT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Corcept Therapeutics (CORT) stake by 26% in Q2 2026, selling an estimated $254K and leaving 11,830 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

Mirae Asset Global ETFs Holdings first reported a position in CORT in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.44M in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 11,830 shares of Corcept Therapeutics worth $1.03M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 4,214 Corcept Therapeutics shares in Q2 2026, an estimated $254K.
  • Corcept Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1617 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Corcept Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Corcept Therapeutics position peaked at $6.44M in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.